Tirzepatide
Research Peptide
Tirzepatide is a dual GIP/GLP-1 receptor agonist studied in incretin and glucose-homeostasis research models.
Product Overview
Tirzepatide is a dual agonist peptide engineered to act at both the GIP and GLP-1 receptors. It serves as a reference compound in research on insulin secretion, gastric emptying, and appetite-regulation pathways.
Evercore Labs LLC supplies Tirzepatide from 5mg up to 120mg per vial across 13 sizes, synthesized to analytical purity and independently third-party tested, with a lot-matched Certificate of Analysis available before purchase.
Research Applications
- Studied as a dual GIP/GLP-1 receptor agonist
- Investigated in insulin-secretion and glucose-homeostasis research
- Used in gastric-emptying and appetite-regulation research
- A reference incretin compound in metabolic research
Compound Specifications
| Purity | ≥99% (HPLC-UV Verified) |
|---|---|
| Appearance | White to off-white lyophilized powder |
| Format | Lyophilized powder, vial |
Storage & Handling
Store lyophilized material at -20°C, protected from light and moisture. Once reconstituted, refrigerate at 2–8°C and use within the timeframe noted on the product COA.
COA & Downloads
Lot-matched Certificates of Analysis for this compound. Each batch is independently tested before release.
Related products
-
Read MoreRetatrutide
Price range: $295.00 through $1,445.00 -
Read MoreSemaglutide
Price range: $195.00 through $505.00 -
Read MoreCagrilintide
Price range: $735.00 through $1,770.00